Evidence map›Paper›PMID 31416420›Full record

ArticleBMC genomics2019

Stoichiometric gene-to-reaction associations enhance model-driven analysis performance: Metabolic response to chronic exposure to Aldrin in prostate cancer.

Igor Marín de Mas, Laura Torrents, Carmen Bedia, Lars K Nielsen, Marta Cascante, Romà Tauler

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Igor Marín de MasThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark. igmar@biosustain.dtu.dk.
Laura TorrentsDepartment of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona 18-24, 08034, Barcelona, Spain.
Carmen BediaDepartment of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona 18-24, 08034, Barcelona, Spain.
Lars K NielsenThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.
Marta CascanteDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Institute of Biomedicine of University of Barcelona (IBUB), Networked Center for Research in Liver and Digestive Diseases (CIBEREHD- CB17/04/00023)) and metabolomics node at INB-Bioinformatics Platform, Instituto de Salud Carlos III (ISCIII, 28029 Madrid), Diagonal 645, 08028, Barcelona, Spain.
Romà TaulerDepartment of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona 18-24, 08034, Barcelona, Spain.
Institute of Environmental Assessment and Water Research · ESNovo Nordisk Foundation · DKInstituto de Salud Carlos III · ES

Funding

FP7 Ideas: European Research Council 320737Novo Nordisk Fonden NNF10CC1016517Novo Nordisk Fonden NNF14OC0009473
6 · The paper itself

Abstract

backgroundGenome-scale metabolic models (GSMM) integrating transcriptomics have been widely used to study cancer metabolism. This integration is achieved through logical rules that describe the association between genes, proteins, and reactions (GPRs). However, current gene-to-reaction formulation lacks the stoichiometry describing the transcript copies necessary to generate an active catalytic unit, which limits our understanding of how genes modulate metabolism. The present work introduces a new state-of-the-art GPR formulation that considers the stoichiometry of the transcripts (S-GPR). As case of concept, this novel gene-to-reaction formulation was applied to investigate the metabolic effects of the chronic exposure to Aldrin, an endocrine disruptor, on DU145 prostate cancer cells. To this aim we integrated the transcriptomic data from Aldrin-exposed and non-exposed DU145 cells through S-GPR or GPR into a human GSMM by applying different constraint-based-methods.

resultsOur study revealed a significant improvement of metabolite consumption/production predictions when S-GPRs are implemented. Furthermore, our computational analysis unveiled important alterations in carnitine shuttle and prostaglandine biosynthesis in Aldrin-exposed DU145 cells that is supported by bibliographic evidences of enhanced malignant phenotype.

conclusionsThe method developed in this work enables a more accurate integration of gene expression data into model-driven methods. Thus, the presented approach is conceptually new and paves the way for more in-depth studies of aberrant cancer metabolism and other diseases with strong metabolic component with important environmental and clinical implications.

Indexed as

AldrinCarnitineCell Line, TumorComputational BiologyEndocrine DisruptorsHumansLipidomicsMaleMetabolic Networks and PathwaysModels, BiologicalProstaglandinsProstatic NeoplasmsTranscriptomeAldrinCarnitineEndocrine DisruptorsProstaglandinsEndocrine disruptorsGenome-scale metabolic modelProstate CancerStoichiometric gene-protein-reaction associationTranscriptomic data integration

Identifiers

PMID31416420
PMCPMC6694502
OpenAlexW2967969769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.